Consideration of Tranexamic Acid Administration to COVID-19 Patients

Physiol Rev. 2020 Oct 1;100(4):1595-1596. doi: 10.1152/physrev.00023.2020.

Authors

Haruhiko Ogawa¹, Hidesaku Asakura¹

Affiliation

¹ Department of Environmental and Preventive Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan; and Department of Hematology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

No abstract available

Keywords: COVID-19; plasmin; thrombosis; tranexamic acid.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Estrone / analogs & derivatives
Fibrinolysin*
Humans
Pandemics*
Pneumonia, Viral*
Risk Factors
SARS-CoV-2
Tranexamic Acid*

Substances

Estrone
Tranexamic Acid
Fibrinolysin
estropipate